Penn TMC: Organ-Specific Project
Penn TMC:特定器官项目
基本信息
- 批准号:10269929
- 负责人:
- 金额:$ 68.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-24 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAdultAnatomyAtlasesBiological AssayCardiovascular DiseasesCellsCellular biologyChromatinChromiumClinicalCollaborationsCommunitiesComputer softwareDataData AnalysesData CollectionDepositionEndocrineEndocrine System DiseasesEndometriumEnsureEnvironmentEpigenetic ProcessFemaleFertilizationFetusGenerationsGeographyGerm CellsGoalsGonadal Steroid HormonesHealthHomeHumanHuman BioMolecular Atlas ProgramHuman bodyImageIn SituInformaticsLifeLocationLongevityMaintenanceMammalian OviductsMapsMedical RecordsMetadataMethodsModalityMolecularOocytesOrganOvaryPeriodicityPersonal SatisfactionPopulationProceduresProcessProductionProteinsProtocols documentationRNARecordsReproductionReproductive BiologyResourcesSamplingSchemeStromal CellsStructureTimeTissue SampleTissuesUterusValidationWalkingWomen&aposs HealthWorkannotation systembody systemcell communitydata standardsdigital modelsembryo/fetusfemale reproductive systemgranulosa cellimplantationindexingmolecular scalemortalitynatural Blastocyst Implantationreproductivereproductive organsample collectionstructured datatheca cellthree-dimensional modeling
项目摘要
The female reproductive system—comprised of the uterus, fallopian tubes and the ovaries—undergoes
some of the most dynamic changes in structure and function of any adult human organ system on a
monthly basis and throughout life. Tissue organization in the female reproductive system is paramount
as it is responsible for the coordinated cyclic changes necessary not only for reproduction but also for the
maintenance of multiple other organ systems. Here, we propose to couple our unique access to the
entire normal female reproductive system with our expertise in single cell biology to establish a multi-
scale molecular map of the female reproductive system. We will collect and manage subject/donor
samples to generate a multi-scale molecular map: We will leverage our subject/donor population to
comprehensively sample up to 22 tissue locations from the same subject (16 donors), as well as sample
a single tissue over a large number of donors to collect temporal information. In total, we propose to
collect ~700 tissue samples over 22 locations from four female reproductive organs using multiple assay
modalities. We will generate a spatially coordinated multi-scale molecular map: We will collect scRNAseq
(3 different schemes), multiplex FISH (clampFISH), in situ open chromatin, as well as simultaneous
RNA/open chromatin assays and protein assays in collaboration with other TMCs for a total of six
different assay methods. We will also develop a 3D digital model of the female reproductive system using
subject/donor imaging data, and develop associated spatial annotation tools to index our clinical sample
collection in SA1 with anatomical coordinates. All assay data will be registered to our 3D anatomical map
that will be integrated with the HIVE Common Coordinate Framework. All metadata from subject records,
clinical procedures, molecular procedures, and informatics pipelines will be collected, curated, and
deposited as structured data. We will use well-validated protocols (e.g., 10X Chromium platform) or
validate and optimize molecular assays before moving them to production pipelines. We will work with
other TMCs as well as other HuBMAP groups to develop community standards and validation methods
for the molecular assays. For systematic data collection and production pipeline work, we will construct a
streamlined process from Clinical Sampling, to 3D Model Indexing, to Molecular Assays, to Data Analysis
and Coordination. The completion of our data collection activities will create an unprecedented public
resource that will enhance our understanding of human reproductive biology and impact women’s health.
女性生殖系统(由子宫,输卵管和卵巢)构成
任何成人人体器官系统的结构和功能上最动态的变化
每月和一生。女性复制系统中的组织组织至关重要
因为它负责不仅需要复制的协调循环变化,而且还需要
维护多个其他器官系统。在这里,我们建议将我们独特地访问
整个正常的女性生殖系统,具有我们在单细胞生物学方面的专业知识,以建立多种
女性生殖系统的比例分子图。我们将收集和管理主题/捐助者
样品生成多尺度的分子图:我们将利用我们的受试者/供体人群
全面采样来自同一受试者(16个捐赠者)的22个组织位置以及样品
在大量捐赠者上进行的单个组织收集临时信息。我们总共建议
使用多个测定
方式。我们将生成一个空间协调的多尺度分子图:我们将收集scrnaseq
(3种不同的方案),多重鱼(夹鱼),原位开放染色质以及同时
与其他TMC合作的RNA/开放染色质分析和蛋白质测定总共六个
不同的测定方法。我们还将使用使用女性生殖系统的3D数字模型
主题/供体成像数据,并开发了相关的空间注释工具来索引我们的临床样本
与解剖坐标的SA1收集。所有测定数据将注册到我们的3D解剖图
这将与Hive Comman Coordic框架集成。所有元数据来自主题记录,
临床程序,分子程序和信息管道将被收集,策划,并且
沉积为结构化数据。我们将使用经过良好验证的协议(例如10倍铬平台)或
在将其转移到生产管道之前,验证和优化分子测定。我们将与
其他TMC以及其他Hubmap组来开发社区标准和验证方法
对于系统的数据收集和生产管道工作,我们将构建一个
简化从临床抽样到3D模型索引,再到分子测定到数据分析的过程
和协调。我们的数据收集活动的完成将创建前所未有的公众
将增强我们对人类生殖生物学的理解并影响妇女健康的资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kurt T Barnhart其他文献
Kurt T Barnhart的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kurt T Barnhart', 18)}}的其他基金
Early Double Low-Dose Aspirin to Reduce Preeclampsia and Miscarriage: a Global Approach RCT
早期双倍低剂量阿司匹林减少先兆子痫和流产:全球方法随机对照试验
- 批准号:
10711793 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别:
Clinical utility of novel biomarkers for prediction of early pregnancy failure
新型生物标志物预测早期妊娠失败的临床应用
- 批准号:
10563608 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别:
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES
CCTN - 避孕临床试验网络 - 女性站点
- 批准号:
8933128 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
Development of a serum biosignature for ectopic pregnancy.
异位妊娠血清生物特征的开发。
- 批准号:
9268010 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
Development of a serum biosignature for ectopic pregnancy.
异位妊娠血清生物特征的开发。
- 批准号:
8846129 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
Development of a serum biosignature for ectopic pregnancy.
异位妊娠血清生物特征的开发。
- 批准号:
8631014 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - FEMALE SITES
CCTN - 避孕临床试验网络 - 女性站点
- 批准号:
10329724 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
Development of a serum biosignature for ectopic pregnancy.
异位妊娠血清生物特征的开发。
- 批准号:
9473793 - 财政年份:2014
- 资助金额:
$ 68.81万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
p16INK4a+ fibroblasts regulate epithelial regeneration after injury in lung alveoli through the SASP
p16INK4a成纤维细胞通过SASP调节肺泡损伤后的上皮再生
- 批准号:
10643269 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别:
Ultrasound-guided Ultra-steerable Histotripsy Array System for Non-invasive treatment of Soft Tissue Sarcoma
超声引导超可控组织解剖阵列系统用于软组织肉瘤的无创治疗
- 批准号:
10649994 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别:
AI-empowered 3D Computer Vision and Image-Omics Integration for Digital Kidney Histopathology
AI 赋能的 3D 计算机视觉和图像组学集成用于数字肾脏组织病理学
- 批准号:
10635439 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别:
Computed tomography muscle size and composition associations with hip and spine bone strength over 4 years: SOMMA-CT
4 年来计算机断层扫描肌肉大小和成分与髋部和脊柱骨强度的关系:SOMMA-CT
- 批准号:
10741630 - 财政年份:2023
- 资助金额:
$ 68.81万 - 项目类别: